Ronald E. Osman
Director, 10% Owner · Inhibitor Therapeutics, Inc.
Individual
- 2025
- Aug 4, 2026
- 2
Other insiders active in the same sector
No other insider has filed at Ronald E. Osman's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- CP Circle ML Holdco GP, LLC - $1.07B in MDLN purchases and sales in the last 12 months
- TC Group Cayman Investment Holdings, L.P. - $1.07B in MDLN purchases and sales in the last 12 months
- Martine A. Rothblatt - $798.23M in UTHR purchases and sales in the last 12 months
- TPG GP A, LLC - $742.97M in LFST purchases and sales in the last 12 months
- GTCR INVESTMENT XI LLC - $639.50M in SHC purchases and sales in the last 12 months
- Keith A. Meister - $591.13M in ILMN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ronald E. Osman?
Ronald E. Osman is a corporate insider, tracked as Director, 10% Owner of Inhibitor Therapeutics, Inc. (INTI). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Ronald E. Osman submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
